Patterns of care and survival for adolescents and young adults with acute leukaemia - A population-based study

British Journal of Cancer

Volumn 79, Issue 3-4, 1999, Pages 658-665

  Stiller, C A ^a   Benjamin, S ^a   Cartwright, R A ^b   Clough, J V ^c   Gorst, D W ^d   Kroll, M E ^a   Ross, J R Y ^e   Wheatley, K ^f   Whittaker, J A ^g   Taylor, P R A ^h   Proctor, S J ^h  

^a UNIVERSITY OF OXFORD   (United Kingdom)

^b UNIVERSITY OF LEEDS   (United Kingdom)

^c Countess of Chester Hospital ^*  (United Kingdom)

^d ROYAL LANCASTER INFIRMARY   (United Kingdom)

^e NORTHAMPTON GENERAL HOSPITAL   (United Kingdom)

^f RADCLIFFE INFIRMARY   (United Kingdom)

^g CARDIFF UNIVERSITY   (United Kingdom)

^h ROYAL VICTORIA INFIRMARY   (United Kingdom)

Author keywords

Acute leukaemia; Clinical trials; Place of treatment; Survival rates

Indexed keywords

ACUTE GRANULOCYTIC LEUKEMIA; ACUTE LEUKEMIA; ACUTE LYMPHOBLASTIC LEUKEMIA; ADOLESCENT; ADULT; ARTICLE; CANCER SURVIVAL; CLINICAL TRIAL; FEMALE; HOSPITAL; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; TEACHING HOSPITAL; UNITED KINGDOM;

ADOLESCENT; ADULT; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CLINICAL TRIALS; DELIVERY OF HEALTH CARE; ENGLAND; FEMALE; HUMANS; LEUKEMIA, LYMPHOCYTIC, ACUTE; LEUKEMIA, NONLYMPHOCYTIC, ACUTE; MALE; REGISTRIES; SURVIVAL ANALYSIS; SURVIVAL RATE; WALES;

EID: 0032928483     PISSN: 00070920     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bjc.6690104     Document Type: Article

References (30)

1. Badrinath P, Day NE and Stockton D (1997) Population-based survival trends for leukaemia in East Anglia, United Kingdom. J Publ Health Med 19: 403-407
2. Benjamin S, Cartwright RA, Clough JV, Gorst DW, Proctor S, Ross JRY, Stiller C, Wheatley K and Whittaker JA (1997) Haematologists' approaches to the management of young adults with acute leukaemia (abstract). Br J Haematol 97 (suppl. 1): 56
3. Cartwright RA, McNally RJQ, Rowland DJ, Thomas J, Gilman E, Gorst D, Morgan G, Prentice A, Staines A and Stiller C (1997) The Descriptive Epidemiology of Leukaemia and Related Conditions in Parts of the United Kingdom 1984-93. Leukaemia Research Fund: London
4. Charlton BG, Taylor PRA and Proctor SJ (1997) The PACE (population-adjusted clinical epidemiology) strategy: a new approach to multi-centre clinical research. Q J Med 90: 147-151
5. Chessells JM, Hall E, Prentice HG, Durrant J, Bailey CC and Richards SM (1998) The impact of age on outcome in lymphoblastic leukaemia; MRC UKALL X and XA compared: a report from the MRC Paediatric and Adult Working Parties. Leukemia 12: 463-473
6. Durrant IJ and Richards SM (1993) Results of Medical Research Council trial UKALL IX in acute lymphoblastic leukaemia in adults; report from the Medical Research Council Working Party on adult leukaemia Br J Haematol 85: 84-92
7. Durrant IJ, Prentice HG and Richards SM (1997) Intensification of treatment for adults with acute lymphoblastic leukaemia: results of U. K. Medical Research Council randomized trial UKALL XA. Br J Haematol 99: 84-92
8. Evensen SA, Brinch L, Tjonnford G, Stavem P and Wisloff F (1994) Estimated 8-year survival of more than 40% in a population-based study of 79 adult patients with acute lymphoblastic leukaemia. Br J Haematol 88: 88-93
9. Expert Advisory Group on Cancer (1995) A Policy Framework for Commissioning Cancer Services (Calman and Hine Report). Department of Health: London
10. Goldstone AH, Lazarus HM, Franklin IM, Richards S, Anderson JW and Rowe JM (1997) Bone marrow transplantation versus chemotherapy in acute lymphoblastic leukaemia. Joint trial of the Medical Research Council (UKALL-12) with the United States Eastern Cooperative Oncology Group E2993. Haematol Blood Trans 38: 700-703.
11. Gorst DW and Johnson KW (1992) Survival in adult leukaemia. Clin Lab Haematol 14: 99-108
12. Hann IM, Stevens RF, Goldstone AH, Rees JKH, Wheatley K, Gray RG and Burnnett AK (1997) Randomised comparison of DAT versus ADE as induction chemotherapy in children and younger adults with acute myeloid leukaemia. Results of the Medical Research Council's 10th AML trial (MRC AML10). Blood 89: 2311-2318
13. Haward RA (1995) Establishing cancer units. Br J Cancer 72: 531-534
14. Kerr DJ, Griffiths R and Edwards B (1996) Delivering cancer care: a model from the West Midlands. Br J Cancer 74: 667-669
15. Marcus RE, Catovsky D, Prentice HG, Newland AC, Chessells JM, Stevens RF, Hann IM, Goldman JM, Hoffbrand AV and Galton DA (1987) Intensive induction and consolidation chemotherapy for adults and children with acute myeloid leukaemia (AML). Joint AML trial 1982-85. Haematol Blood Trans 30: 346-351
16. Nachman J, Sather HN, Buckley JD, Gaynon PS, Steinherz PG, Tubergen DG, Lampkin BC and Hammond GD (1993) Young adults 16-21 years of age at diagnosis entered on Childrens Cancer Group acute lymphoblastic leukaemia and acute myeloblastic leukaemia protocols. Results of treatment. Cancer 71: 3377-3385.
17. Proctor SJ (1994) Acute lymphoblastic leukaemia in adults: the case for a strategic shift in study approach. Br J Haematol 88: 229-233
18. Proctor SJ, Taylor P, Thompson RB, Finney R, Reid MM, Hamilton PJ, Saunders P, Fail B, Dickinson A, Paul B, Qureshi M, Tinegate H, Lennard A, Stainsby D, Goff D, Kay L, Cartner R, Mamood A, Bird T, Condie P, Collins A, Abela M, Renwick L, Walker W and Evans RGB (1985) Acute lymphoblastic leukaemia in adults in the Northern Region of England - a study of 75 cases. Q J Med 57: 761-774
19. Proctor SJ, Taylor PRA, Stark A, Carey PJ, Bown N, Hamilton PJ and Reid MM (1995) Evaluation of the impact of allogeneic transplant in first remission on an unselected population of patients with acute myeloid leukaemia aged 15-55 years. Leukemia 9: 1246-1251
20. Rees JKH, Gray RG and Wheatley K (1996) Dose intensification in acute myeloid leukaemia: greater effectiveness at lower cost. Principal report of the Medical Research Council's AML 9 study. Br J Haematol 94: 89-98
21. Secker-Walker LM, Prentice HG, Durrant J, Richards S, Hall E and Harrison G (1997) Cytogenetics adds independent prognostic information in adults with acute lymphoblastic leukaemia on MRC trial UKALL XA. Br J Haematol 96: 601-610
22. Selby P, Gillis C and Haward R (1996) Benefits from specialised cancer care. Lancet 348: 313-318
23. Souhami RL, Whelan J, McCarthy JF and Kilby A (1996) Benefits and problems of an adolescent oncology unit. In Cancer and the Adolescent, Selby P and Bailey C (eds), pp. 276-283. BMJ: London
24. Stiller CA (1994a) Population based survival rates for childhood cancer in Britain, 1980-91. BMJ 309: 1612-1616
25. Stiller CA (1994b) Centralised treatment, entry to trials and survival. Br J Cancer 70: 352-362
26. Stiller CA and Draper GJ (1989) Treatment centre size, entry to trials and survival in acute lymphoblastic leukaemia. Arch Dis Child 64: 657-661
27. Stiller CA and Eatock EM (1994) Survival from acute non-lymphocytic leukaemia, 1971-88: a population-based study. Arch Dis Child 70: 219-223
28. Taylor I (1996) Problems of site specific cancer specialisation. BMJ 313: 1213
29. Warrell RP, Frankel SR, Miller WH, Scheinberg DA, Itri LM, Hittelman WN, Vyms R, Andreeff M, Tafuri A, Jakubowski A, Gabrilove J, Gordon MS and Dmitrovsky E (1991) Differentiation therapy of acute promyelocytic leukaemia with tretinoin (all-trans-retinoic acid). N Engl J Med 324: 1385-1393
30. Youngson JHAM, Jones JM, Chang JG, Harris M and Banergee SS (1995) Treatment and survival of lymphoid malignancy in the north-west of England: a population-based study. Br J Cancer 72: 757-765